Ultragenyx Pharmaceutical (RARE) Prepaid Assets (2013 - 2026)

Ultragenyx Pharmaceutical (RARE) has 14 years of Prepaid Assets data on file, last reported at $68.0 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $68.0 million, up 13.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $68.0 million (up 13.63% YoY), and the FY2025 annual result was $61.0 million, up 52.5% from the prior year.
• Prepaid Assets climbed to $68.0 million in Q1 2026 per RARE's latest filing, from $61.0 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $77.5 million in Q2 2022 and troughed at $40.0 million in Q4 2024.
• A 5-year average of $57.6 million and a median of $59.8 million in 2025 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2023 and 2025: Prepaid Assets plunged 35.15% in 2023, then soared 52.5% in 2025.
• A 5-year view of Prepaid Assets shows it stood at $68.9 million in 2022, then sank by 30.92% to $47.6 million in 2023, then retreated by 15.99% to $40.0 million in 2024, then surged by 52.5% to $61.0 million in 2025, then increased by 11.48% to $68.0 million in 2026.
• Business Quant data shows RARE's Prepaid Assets at $68.0 million in Q1 2026, $61.0 million in Q4 2025, and $53.2 million in Q3 2025.